Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantation

Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantation

Leukemia advance online publication, August 29 2017.
doi:10.1038/leu.2017.256

Authors: R Chakraborty, E Muchtar, S K Kumar, F K Buadi, D Dingli, A Dispenzieri, S R Hayman, W J Hogan, P Kapoor, M Q Lacy, N Leung, R Warsame, T Kourelis, W Gonsalves & M A Gertz

Source: Leukemia - August 29, 2017 Category: Hematology Authors: R Chakraborty E Muchtar S K Kumar F K Buadi D Dingli A Dispenzieri S R Hayman W J Hogan P Kapoor M Q Lacy N Leung R Warsame T Kourelis W Gonsalves M A Gertz Source Type: research